Tetracyclines inhibit activated B cell function
Open Access
- 1 July 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 13 (7), 921-931
- https://doi.org/10.1093/intimm/13.7.921
Abstract
Tetracyclines have recently been shown to exert a number of pleiotropic anti-inflammatory and immunomodulatory activities, independent of their antibiotic properties. These include the ability to inhibit metalloproteinases (MP), a class of enzymes involved in crucial cellular functions such as the shedding of soluble mediators and their receptors from the cell surface, as well as interaction with, and remodeling of, the extracellular matrix. Here we report that doxycycline at therapeutic concentrations (1–5 μg/ml) significantly suppresses Ig secretion and class switching by in vitro activated murine B cells. Suppression of Ig secretion correlates with a decrease in levels of mRNA for the terminal B cell differentiation-associated genes Blimp-1 and mad-4, as well as to a reduction in expression of the plasma cell markers Syndecan-1 and J chain. Inhibition of class switching occurs at the recombination stage and is also induced by other MP inhibitors, including tetracycline analogs lacking antibiotic activity and the chemically unrelated hydroxamate KB8301. These novel, direct effects of MP inhibitors on B lymphocytes suggest an intrinsic role for MP in B cell activation and likely explain some of the observed in vivo immunomodulatory properties of tetracyclines. Moreover, these findings have significant implications for tetracycline therapy in Ig-mediated autoimmune or allergic diseases and raise questions about the use of doxycycline-inducible transgenic systems for the study of B cell function.Keywords
This publication has 50 references indexed in Scilit:
- Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 familyEuropean Journal of Immunology, 1999
- Doxycycline Induces Fas/Fas Ligand-Mediated Apoptosis in Jurkat T LymphocytesBiochemical and Biophysical Research Communications, 1999
- Tumor necrosis factor receptor family members in the immune systemSeminars in Immunology, 1998
- Erratum: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-αNature, 1997
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences of the United States of America, 1996
- The influence of tetracyclines on T cell activationClinical and Experimental Immunology, 1995
- Regulation of murine B cell growth and differentiation by CD30 ligandEuropean Journal of Immunology, 1995
- IFN-γ represses ε germline transcription and subsequently down-regulates switch recombination to εInternational Immunology, 1994
- Structural biochemistry and activation of matrix metalloproteasesCurrent Opinion in Cell Biology, 1993
- The effects of minocycline and tetracycline on the mitotic response of human peripheral blood lymphocytesJournal of Antimicrobial Chemotherapy, 1991